These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 28199067)
1. Human epididymis protein 4 immunostaining of malignant ascites differentiates cancer of Müllerian origin from gastrointestinal cancer. Stiekema A; Van de Vijver KK; Boot H; Broeks A; Korse CM; van Driel WJ; Kenter GG; Lok CA Cancer Cytopathol; 2017 Mar; 125(3):197-204. PubMed ID: 28199067 [TBL] [Abstract][Full Text] [Related]
2. Serum human epididymal protein 4 (HE4) as biomarker for the differentiation between epithelial ovarian cancer and ovarian metastases of gastrointestinal origin. Stiekema A; Boldingh QJ; Korse CM; van der Noort V; Boot H; van Driel WJ; Kenter GG; Lok CA Gynecol Oncol; 2015 Mar; 136(3):562-6. PubMed ID: 25560808 [TBL] [Abstract][Full Text] [Related]
3. SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type. Moh M; Krings G; Ates D; Aysal A; Kim GE; Rabban JT Am J Surg Pathol; 2016 Mar; 40(3):419-32. PubMed ID: 26551622 [TBL] [Abstract][Full Text] [Related]
4. Discrepant clinicopathologic characteristics and HE4 performance in type I and type II epithelial ovarian cancer. Jiang J; Bo D; Chang X; Cheng H; Ye X; Cui H Int J Clin Exp Med; 2015; 8(11):21303-10. PubMed ID: 26885070 [TBL] [Abstract][Full Text] [Related]
5. The role of human epididymis protein 4 in the diagnosis of epithelial ovarian cancer. Jia LT; Zhang YC; Li J; Tian Y; Li JF Clin Transl Oncol; 2016 Mar; 18(3):233-9. PubMed ID: 26220095 [TBL] [Abstract][Full Text] [Related]
6. Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas. Drapkin R; von Horsten HH; Lin Y; Mok SC; Crum CP; Welch WR; Hecht JL Cancer Res; 2005 Mar; 65(6):2162-9. PubMed ID: 15781627 [TBL] [Abstract][Full Text] [Related]
7. Ovarian cancer and normal fallopian tube high WFDC2 expression does not correlate with HE4 serum level. Gąsiorowska E; Walkowiak GP; Warchoł W; Lemańska A; Jankowska A; Nowak-Markwitz E Ginekol Pol; 2015 May; 86(5):335-9. PubMed ID: 26117969 [TBL] [Abstract][Full Text] [Related]
8. [Cytopathological characterization of ascites for the diagnosis of serous ovarian carcinoma]. Chang YH; Zou BQ; Cai Y; Yang SD; Zhang Y; Liang JB; Li C Zhonghua Zhong Liu Za Zhi; 2023 May; 45(5):424-432. PubMed ID: 37188628 [No Abstract] [Full Text] [Related]
9. A comprehensive analysis of PAX8 expression in human epithelial tumors. Laury AR; Perets R; Piao H; Krane JF; Barletta JA; French C; Chirieac LR; Lis R; Loda M; Hornick JL; Drapkin R; Hirsch MS Am J Surg Pathol; 2011 Jun; 35(6):816-26. PubMed ID: 21552115 [TBL] [Abstract][Full Text] [Related]
10. Serum HE4 superior to CA125 in predicting poorer surgical outcome of epithelial ovarian cancer. Shen Y; Li L Tumour Biol; 2016 Nov; 37(11):14765-14772. PubMed ID: 27629144 [TBL] [Abstract][Full Text] [Related]
11. Tissue HE4 Expression Discriminates the Ovarian Serous Carcinoma but Not the Uterine Serous Carcinoma Patients. A New Adjunct to the Origin of the Tumor Site. Celik B; Bulut T; Yalcin AD Pathol Oncol Res; 2020 Apr; 26(2):1145-1151. PubMed ID: 31165997 [TBL] [Abstract][Full Text] [Related]
12. Pax8: a marker for carcinoma of Müllerian origin in serous effusions. Tong GX; Devaraj K; Hamele-Bena D; Yu WM; Turk A; Chen X; Wright JD; Greenebaum E Diagn Cytopathol; 2011 Aug; 39(8):567-74. PubMed ID: 20607683 [TBL] [Abstract][Full Text] [Related]
13. PAX8: a sensitive and specific marker to identify cancer cells of ovarian origin for patients prior to neoadjuvant chemotherapy. Wang Y; Wang Y; Li J; Yuan Z; Yuan B; Zhang T; Cragun JM; Kong B; Zheng W J Hematol Oncol; 2013 Aug; 6():60. PubMed ID: 23958394 [TBL] [Abstract][Full Text] [Related]
14. Immunohistochemistry in the Diagnosis of Mucinous Neoplasms Involving the Ovary: The Added Value of SATB2 and Biomarker Discovery Through Protein Expression Database Mining. Strickland S; Wasserman JK; Giassi A; Djordjevic B; Parra-Herran C Int J Gynecol Pathol; 2016 May; 35(3):191-208. PubMed ID: 26535987 [TBL] [Abstract][Full Text] [Related]
15. Low-grade ovarian serous neoplasms (low-grade serous carcinoma and serous borderline tumor) associated with high-grade serous carcinoma or undifferentiated carcinoma: report of a series of cases of an unusual phenomenon. Boyd C; McCluggage WG Am J Surg Pathol; 2012 Mar; 36(3):368-75. PubMed ID: 22082603 [TBL] [Abstract][Full Text] [Related]
16. Analysis of serum HE4 levels in various histologic subtypes of epithelial ovarian cancer and other malignant tumors. Blackman A; Mitchell J; Rowswell-Turner R; Singh R; Kim KK; Eklund E; Skates S; Bast RC; Messerlian G; Miller MC; Moore RG Tumour Biol; 2021; 43(1):355-365. PubMed ID: 34957977 [TBL] [Abstract][Full Text] [Related]
17. The value of PAX8 and WT1 molecules in ovarian cancer diagnosis. Liliac L; Carcangiu ML; Canevari S; Căruntu ID; Ciobanu Apostol DG; Danciu M; Onofriescu M; Amălinei C Rom J Morphol Embryol; 2013; 54(1):17-27. PubMed ID: 23529305 [TBL] [Abstract][Full Text] [Related]
18. Human epididymis protein 4 is up-regulated in gastric and pancreatic adenocarcinomas. O'Neal RL; Nam KT; LaFleur BJ; Barlow B; Nozaki K; Lee HJ; Kim WH; Yang HK; Shi C; Maitra A; Montgomery E; Washington MK; El Rifai W; Drapkin RI; Goldenring JR Hum Pathol; 2013 May; 44(5):734-42. PubMed ID: 23084584 [TBL] [Abstract][Full Text] [Related]